About
Tevogen Bio Holdings Inc (NASDAQ:TVGN) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 26 2026
Tevogen Advances Strategic CRO Evaluation to Expand Clinical Research Delivery Capabilities and Drive Revenue Growth
Mar 25 2026
Tevogen Regains Compliance with Nasdaq Minimum Bid Price Requirement
Mar 18 2026
Tevogen CIO and Head of Tevogen.AI Mittul Mehta to Speak at Microsoft Fabric Community Conference (FabCon 2026)
Mar 13 2026
Tevogen.AI Reports Advancements in PredicTcell™ Beta, Demonstrates Improved Precision Metrics and Expands Proprietary AI Infrastructure
Mar 13 2026
Tevogen Reaffirms Capital Discipline as Lead Investor Maintains Holdings and Company Limits Share Utilization
Financials
Revenue
$0
Market Cap
$24.4 M
EPS
-8.08
Translate